NCT06647550: To Assess the Efficacy and Safety of HD-6277 in Adult Patients With Inadequate Control of Type 2 Diabetes Mellitus by Diet and Exercise
- State
- Under way
- Phase
- Phase 2
- People
- 160 planned
- Started
- 12 Dec 2024
- Primary completion
- 31 Mar 2025
- Arms
- HD-6277 50mg tab
- Results
- None posted
- 18 Oct 2024: Trial registered
- 12 Dec 2024: Trial started